 |
|
Ronald Scott, Chief Financial Officer, is a Swiss citizen. Mr. Scott obtained undergraduate and graduate degrees in planning with emphasis in finance. Prior to joining Basilea, he worked for nine years at Roche in management positions in Pharmaceutical Finance, Licensing, and the Roche Corporate Finance Mergers and Acquisitions group. His assignments included managing Roche’s call, primary and secondary offerings on Genentech; Roche’s biotechnology investment portfolio; acquisitions and divestitures. Prior to joining Roche, Mr. Scott worked for Prudential Investment Corporation in the United States as director in Prudential’s Finance and International Business Development Units, managing divestitures and joint venture transactions. |